Howard Hughes (HHH) director awarded 2,464 restricted shares at $0
Howard Hughes Holdings Inc. (HHH) reported an insider equity award.
Rhea-AI Filing Summary
Howard Hughes Holdings Inc. (HHH) reported an insider equity award. Director Thom Lachman received 2,464 restricted shares of common stock on 10/24/2025 at a $0 grant price under the company’s 2025 Equity Incentive Plan.
The award vests on the earlier of one year from grant or the day of the company’s 2026 annual meeting of stockholders, but not less than 50 weeks. Following this grant, the filing lists 2,464 shares beneficially owned, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,464 shares
Grant/Award
1 txn
Insider
Lachman Thomas Cecil
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common stock, $0.01 par value | 2,464 | $0.00 | $0.00 |
Holdings After Transaction:
Common stock, $0.01 par value — 2,464 shares (Direct)
Footnotes (1)
- F1. Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan. The shares vest on the earlier of one year from the date of grant or the day of the Issuer's 2026 annual meeting of stockholders (but not less than 50 weeks).
FAQ
What did Howard Hughes (HHH) disclose in this Form 4?
A director, Thom Lachman, was granted 2,464 restricted shares on 10/24/2025 at a $0 grant price.
What is the vesting schedule for the HHH director’s restricted stock?
The shares vest on the earlier of one year from grant or the 2026 annual meeting, but not less than 50 weeks.
What plan governed the restricted stock grant at HHH?
The award was made under the company’s 2025 Equity Incentive Plan for non-employee directors.
What is the reporting person’s relationship to Howard Hughes (HHH)?
The reporting person is a Director of Howard Hughes Holdings Inc.
AI-generated analysis. How Rhea-AI works. Not financial advice.